FDA Approves New Kyprolis (carfilzomib) Combination Regimen with Darzalex (daratumumab) and Dexamethasone in Both Once- And Twice-Weekly Dosing Regimens

THOUSAND OAKS, Calif., Aug. 20, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved the expansion of the Kyprolis (carfilzomib) U.S. prescribing information to include its use in...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news